Abstract

The hepatitis E virus (HEV) ORF2 encodes a single structural capsid protein. The E2s domain (amino acids 459-606) of the capsid protein has been identified as the major immune target. All identified neutralizing epitopes are located on this domain; however, a comprehensive characterization of antigenic sites on the domain is lacking due to its high degree of conformation dependence. Here, we used the statistical software SPSS to analyze cELISA (competitive ELISA) data to classify monoclonal antibodies (mAbs), which recognized conformational epitopes on E2s domain. Using this novel analysis method, we identified various conformational mAbs that recognized the E2s domain. These mAbs were distributed into 6 independent groups, suggesting the presence of at least 6 epitopes. Twelve representative mAbs covering the six groups were selected as a tool box to further map functional antigenic sites on the E2s domain. By combining functional and location information of the 12 representative mAbs, this study provided a complete picture of potential neutralizing epitope regions and immune-dominant determinants on E2s domain. One epitope region is located on top of the E2s domain close to the monomer interface; the other is located on the monomer side of the E2s dimer around the groove zone. Besides, two non-neutralizing epitopes were also identified on E2s domain that did not stimulate neutralizing antibodies. Our results help further the understanding of protective mechanisms induced by the HEV vaccine. Furthermore, the tool box with 12 representative mAbs will be useful for studying the HEV infection process.

Highlights

  • The E2s domain of hepatitis E virus (HEV) capsid protein is the major target for antibody response

  • HRP-conjugated monoclonal antibodies (mAbs) were added at selected dilutions that resulted in optical density (OD) readings of ϳ1.5 in the indirect enzyme-linked immunosorbent assay (ELISA)

  • Twenty-three mAbs Recognizing Conformational Epitopes Located on the E2s Domain Were Obtained from an Anti-HEV Panel Containing 96 mAbs—A total of 96 mAbs that recognized the HEV capsid protein were obtained from mice immunized with recombinant truncated ORF2 protein p239. 10-Fold serially diluted mAbs were used to quantitatively determine their reactivities with p239

Read more

Summary

Background

The E2s domain of hepatitis E virus (HEV) capsid protein is the major target for antibody response. Results: Six antigenic sites of the E2s domain were identified by constructing, clustering, and characterizing a tool box containing representative anti-HEV monoclonal antibodies. We used the statistical software SPSS to analyze cELISA (competitive ELISA) data to classify monoclonal antibodies (mAbs), which recognized conformational epitopes on E2s domain. By combining functional and location information of the 12 representative mAbs, this study provided a complete picture of potential neutralizing epitope regions and immune-dominant determinants on E2s domain. Studies of the antigenic sites on the E2s domain are necessary to understand the host antibody response to HEV and the molecular mechanisms of HEV infection. This study provided new data on the function of the HEV E2s domain that will increase our understanding of the mechanisms of HEV vaccine-induced protection

Experimental Procedures
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call